BigSis
Reading
About BigSis
BigSis’ chemical-free insect control solutions are more effective than insecticides and perfect for biodiversity – species-specific, non-toxic and non-GM. BigSis has reinvented the sterile insect technique using robotics and artificial intelligence to create a proprietary platform that generates dozens of blockbuster solutions with low or no regulatory requirement and excellent return on investment for growers. Its first solution has demonstrated season long control of spotted wing drosophila (SWD) and achieved first sales. BigSis sterile male insects, which mate with wild females to control pest populations, are non-GM, non-toxic and are benign to other species, including pollinators and beneficial insects. Starting with spotted wing Drosophila (SWD), a hard-to-control pest of soft fruit, and codling moth, a major apple pest, BigSis will develop, test and commercialise a series of insect control solutions for farmers and mosquito control agencies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: bigsis.tech
- Phone: [email protected]
Industries & Categories
Agriculture, AgTech, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/bigsis-57087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.